Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
INPP5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SIRPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927416 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HOXB-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6778 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IKZF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EWSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSTYK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF556 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SACS-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on